Tag: psychiatric medication


ZIPRASIDONE

Introduction to Ziprasidone and Its Pharmacological Classification Ziprasidone, commonly known by its brand name Geodon, represents a significant advancement in the field of neuropsychopharmacology as a second-generation or atypical antipsychotic agent. Originally approved by the United States Food and Drug Administration (FDA) in 2001, this benzisothiazolyl piperazine derivative was developed to address the complex symptomatology […]

Read More

PROTRIPTYLINE

Introduction and Definition Protriptyline is classified as a tricyclic antidepressant (TCA), a class of psychotropic medications historically fundamental in the treatment of various mood disorders. Specifically, protriptyline is utilized primarily in the management of major depressive disorder (MDD). While TCAs have largely been supplanted as first-line treatments by newer agents, such as selective serotonin reuptake […]

Read More

NOMIFENSINE

Introduction to Nomifensine: Classification and History Nomifensine, often recognized by its trade name Merital, represents a unique pharmacological entity within the realm of psychotropic medications, particularly antidepressants. Structurally, it is classified as a tetrahydroisoquinoline derivative, distinguishing it significantly from the tricyclic antidepressants (TCAs) and monoamine oxidase inhibitors (MAOIs) that dominated the market during its development […]

Read More

DOPAMINE-RECEPTOR ANTAGONISTS

Introduction and Definition of Dopamine Receptor Antagonists Dopamine-receptor antagonists (DRAs), often simply referred to as dopamine antagonists, represent a crucial class of pharmacological agents utilized primarily in the field of psychopharmacology. Fundamentally, these substances operate by binding to and blocking the action of the neurotransmitter dopamine at its designated receptor sites within the central nervous […]

Read More

TRANYLCYPROMINE

Classification and Core Definition Tranylcypromine, classified formally as a non-hydrazine derivative, is a potent and irreversible inhibitor of the enzyme monoamine oxidase, placing it squarely within the class of compounds known as monoamine oxidase inhibitors, or MAOIs. This pharmaceutical agent functions as a highly effective antidepressant, although its usage is typically reserved for individuals suffering […]

Read More

MOOD STABILIZERS

are used to reduce the symptoms of mania or manic episodes during the general treatment of cyclic mood disorders including both bipolar disorders and cyclothymic disorder. Because of the high risk of suicide or attempted suicide with disorders such as dipolar disorder, caution must be taken when prescribing medications which can be potentially lethal when […]

Read More